Spots Global Cancer Trial Database for capecitabine (xeloda)

Every month we try and update this database with for capecitabine (xeloda) cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Preoperative Chemoradiotherapy and Transanal Endoscopic Microsurgery Versus Total Mesorectal Excision in T2-T3s N0, M0 Rectal Cancer	NCT01308190	Rectal Cancer	Capecitabine (X... 50.4 Gy Transanal Endos... Total Mesorecta...	18 Years -	Corporacion Parc Tauli
Irinotecan/Cetuximab Followed by XELOX/Cetuximab vs the Reverse Sequence in Metastatic CRC	NCT00755534	Colorectal Canc...	Irinotecan Capecitabine Cetuximab Oxaliplatin	18 Years - 72 Years	Hellenic Oncology Research Group
Study of Gemcitabine and Herceptin Versus Xeloda and Herceptin in HER-2 (+) Metastatic Breast Cancer Patients	NCT00440622	Breast Cancer	Gemcitabine Herceptin Capecitabine (X...	18 Years - 75 Years	Hellenic Oncology Research Group
Bevacizumab Plus Capecitabine (Xeloda) in Patients With Untreated Metastatic Colorectal Cancer	NCT00203411	Colorectal Canc...	Capecitabine (X... Bevacizumab	18 Years -	Translational Oncology Research International
Preoperative Chemoradiotherapy and Transanal Endoscopic Microsurgery Versus Total Mesorectal Excision in T2-T3s N0, M0 Rectal Cancer	NCT01308190	Rectal Cancer	Capecitabine (X... 50.4 Gy Transanal Endos... Total Mesorecta...	18 Years -	Corporacion Parc Tauli
Dose Escalation Study Combining Oral Capecitabine (Xeloda) and Radiotherapy for Patients With Unresectable Liver or Cholangiocarcinoma	NCT00216437	Cancer of Liver	Capecitabine (X...	18 Years -	James A. Haley Veterans Administration Hospital
Phase I Dose Escalation of Stereotactic Radiosurgical Boost for Locally Advanced Esophageal Cancer	NCT00368329	Esophageal Neop... Carcinoma, Squa... Adenocarcinoma Esophageal Canc...	Capecitabine (X... [18-F] Fluorode... 5-Fluorouracil ... Carboplatin	18 Years -	Stanford University
Study of Gemcitabine and Herceptin Versus Xeloda and Herceptin in HER-2 (+) Metastatic Breast Cancer Patients	NCT00440622	Breast Cancer	Gemcitabine Herceptin Capecitabine (X...	18 Years - 75 Years	Hellenic Oncology Research Group
XELOX III. Xeloda in Combination With Eloxatin for Patients With Advanced or Metastatic Colorectal Cancer	NCT00212615	C04.588.274.476...	Oxaliplatin (El... Capecitabine (X...	18 Years -	Odense University Hospital
Phase I Dose Escalation of Stereotactic Radiosurgical Boost for Locally Advanced Esophageal Cancer	NCT00368329	Esophageal Neop... Carcinoma, Squa... Adenocarcinoma Esophageal Canc...	Capecitabine (X... [18-F] Fluorode... 5-Fluorouracil ... Carboplatin	18 Years -	Stanford University
Efficacy of Capecitabine Metronomic Chemotherapy to Triple-negative Breast Cancer	NCT01112826	Breast Cancer	Capecitabine	18 Years - 70 Years	Sun Yat-sen University
Docetaxel and Carboplatin Followed by Oral Capecitabine, Docetaxel and Radiation for Esophageal Cancer	NCT00153881	Esophageal Neop...	Capecitabine (X...	18 Years -	Dartmouth-Hitchcock Medical Center
Bevacizumab Plus Capecitabine (Xeloda) in Patients With Untreated Metastatic Colorectal Cancer	NCT00203411	Colorectal Canc...	Capecitabine (X... Bevacizumab	18 Years -	Translational Oncology Research International
Immunochemotherapy for Metastatic Renal Cell Carcinoma	NCT00226798	Adenocarcinoma ...	Capecitabine (X...	18 Years - 80 Years	Rambam Health Care Campus
Gemcitabine and Capecitabine in Patients With Advanced Pancreatic Cancer	NCT00316420	Pancreatic Canc...	Capecitabine (X... Gemcitabine	18 Years -	Swedish Medical Center

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: